{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"13.700","floor":"12.100"},"ipodate":{"start":"2020-10-13 00:00:00","end":"2020-10-19 00:00:00"},"minimumcapital":"13838.06","subscribed":"589.47","marketcap":"356.98億","H_marketcap":"--","pe":"31.95","codesrate":"5.00","link":"https://staticpdf.iqdii.com/stockdata/notice/02096/2020/2020101300006_c.pdf","ipopricing":"13.700","resultdate":"2020-10-23 00:00:00","enddate":"2020-10-19 00:00:00","listeddate":"2020-10-27 00:00:00","issuenumber":"26056.90萬","issuenumberhK":"13028.50萬","issuenumberother":"13028.40萬","grayprice":"11.18","sponsors":"摩根士丹利亞洲有限公司,中國國際金融香港證券有限公司","raisemoney":"339240.00萬","use":"1、約60%（或2,035.4百萬港元）將分配予我們在戰略重點治療領域中選定的在研產品的持續研發；\n2、約10%（或339.2百萬港元）將分配予加強我們的銷售及營銷能力；\n3、約10%（或339.2百萬港元）將分配予我們于未來幾年投資醫藥或生物技術領域的公司，以拓寬我們的產品組合；\n4、約10%（或339.2百萬港元）將分配予償還如下表所示的若干未償還銀行貸款；\n5、約10%（或339.2百萬港元）將用作營運資金及其他一般企業用途。","shares":1000,"leadagent":"摩根士丹利亞洲有限公司,中國國際金融香港證券有限公司,瑞士銀行香港分行,招銀國際融資有限公司,信銀(香港)資本有限公司","bookrunners":"摩根士丹利亞洲有限公司,中國國際金融香港證券有限公司,瑞士銀行香港分行,招銀國際融資有限公司","coordinator":"摩根士丹利亞洲有限公司,中國國際金融香港證券有限公司,瑞士銀行香港分行","firstDayOpen":"11.00","IsEiio":0,"Interestdays":4,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"摩根士丹利亞洲有限公司","code":"E02096","name":"先聲藥業","fullname":"先聲藥業集團有限公司"},"institutioninfo":{"principaloffice":"中國江蘇省南京市玄武區玄武大道699-18號","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"任晉生","secretary":"鮑軍,馮潔,麥寶文","telephone":"(8625) 8556 6366","substantialshareholders":"先聲藥業控股(45.90%),雅景環球(23.29%)","principalactivities":"公司是一家從事藥品研發、生產和商業化的公司，目前主要從事仿制藥業務。","website":"http://www.simcere.com"},"managerinfo":[{"managername":"任晉生","post":"董事長、首席執行官兼執行董事","rankno":1},{"managername":"張誠","post":"首席運營官兼執行董事","rankno":2},{"managername":"萬玉山","post":"首席財務官兼執行董事","rankno":3}],"investorinfo":[{"institutionname":"Hillhouse Funds","shareholding":"28,285,000.0","percentage":10.86,"ReleaseDate":"2021-04-27 00:00:00","relatedparty":"Hillhouse Capital","subsidiary":["Gaoling Fund, L.P.","Hillhouse Funds","Gaoling Yali Fund, L.P.","HHJH Holdings Limited"],"InverstorType":"基金"},{"institutionname":"高新(香港)有限公司","shareholding":"22,628,000.0","percentage":8.68,"ReleaseDate":"2021-04-27 00:00:00","relatedparty":"南京江北新區產業投資集團有限公司","subsidiary":["高新(香港)有限公司"],"InverstorType":"公司"},{"institutionname":"紅土創新國際有限公司","shareholding":"16,970,000.0","percentage":6.51,"ReleaseDate":"2021-04-27 00:00:00","relatedparty":"深圳市創新投資集團有限公司","subsidiary":["紅土創新國際有限公司","SCGC資本控股有限公司"],"InverstorType":"公司"},{"institutionname":"Lake Bleu Prime Healthcare Master Fund Limited","shareholding":"14,142,000.0","percentage":5.43,"ReleaseDate":"2021-04-27 00:00:00","relatedparty":"清池資本(香港)有限公司","subsidiary":["Lake Bleu Prime Healthcare Master Fund Limited"],"InverstorType":"基金"}],"TotalShareholdingPercentage":41.25},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":6}